Literature DB >> 28389055

Primary Amebic Meningoencephalitis in Children: A Report of Two Fatal Cases and Review of the Literature.

Robert C Stowe1, Davut Pehlivan2, Katie E Friederich2, Michael A Lopez2, Shannon M DiCarlo2, Varina L Boerwinkle2.   

Abstract

BACKGROUND: Primary amebic meningoencephalitis is a rare, almost uniformly fatal disease of cerebral invasion by Naegleria fowleri, occurring most commonly after swimming in warm fresh water in summer months. Treatment using the experimental medication miltefosine demonstrated improved survival and favorable neurocognitive outcome in a 2013 North American patient. There is little information about the electroencephalographic findings of such patients, and our understanding of factors predicting survival is limited. METHODS AND
RESULTS: We describe two children, aged four and 14 years, who both presented with seizures and altered mental status after recent fresh water swimming exposures. With evidence of pyogenic meningitis and examination of cerebrospinal fluid demonstrating motile trophozoites on wet mount, N. fowleri meningoencephalitis was diagnosed. Amebicidal antibiotic regimens with miltefosine were administered. Continuous electroencephalography monitoring demonstrated evolution from diffuse slowing to seizures, status epilepticus, and eventually global attenuation and absence of activity. Both patients ultimately died after complications of progressive increasing intracranial pressure and hemodynamic compromise.
CONCLUSIONS: Primary amebic meningoencephalitis is a serious, sporadic infection. We describe two fatal pediatric patients, the evolution of their electroencephalography findings, and compare their findings with the 13 reported pediatric survivors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Naegleria fowleri; continuous EEG; miltefosine; status epilepticus

Mesh:

Year:  2017        PMID: 28389055     DOI: 10.1016/j.pediatrneurol.2017.02.004

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing.

Authors:  Qiang Wang; Jianming Li; Jingkai Ji; Liuqing Yang; Li Chen; Rongrong Zhou; Yang Yang; Haixia Zheng; Jing Yuan; Liqiang Li; Yuhai Bi; George F Gao; Jinmin Ma; Yingxia Liu
Journal:  BMC Infect Dis       Date:  2018-07-28       Impact factor: 3.090

2.  Case Report and Literature Review: Bacterial Meningoencephalitis or Not? Naegleria fowleri Related Primary Amoebic Meningoencephalitis in China.

Authors:  Wenjuan Zhou; Yuzhen Ouyang; Di Zhang; Sheng Liao; Hui Liang; Lingling Zhao; Chunyuan Chen
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.569

Review 3.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

4.  Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis.

Authors:  Maarten J Sarink; Aloysius G M Tielens; Annelies Verbon; Robert Sutak; Jaap J van Hellemond
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.